Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

MedImmune, 3M Drug Delivery Partner
Tuesday, September 29, 2015
The collaboration will focus on developing next generation toll-like receptor (TLR) agonists - promising agents that activate innate immune cells and enhance the visibility of cancer tumors.

Opening the Door to Safer, More Precise Cancer Therapies
Tuesday, September 29, 2015
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.

Novasep Strengthens its Advisory Board
Tuesday, September 29, 2015
Professors Alois Fürstner and Alois Jungbauer, renowned experts in catalysis and purification processes, will help boost innovation at Novasep

Sorrento Therapeutics Form LA Cell
Tuesday, September 29, 2015
Sorrento Therapeutics, Inc. have announced that they have formed a new company – named LA Cell, Inc. (LA Cell) – to focus on the development of groundbreaking cell-penetrating antibody therapies.

DARPA Awards $32 Million Contract to MIT, Broad Institute Foundry
Monday, September 28, 2015
A facility at the Broad Institute of MIT and Harvard and MIT that aims to achieve the full potential of engineering biology has received a five-year, $32 million contract from the Defense Advanced Research Projects Agency (DARPA).

Vaccination On The Horizon For Severe Viral Infection Of The Brain
Monday, September 28, 2015
Researchers from the University of Zurich and the University Hospital Zurich reveal possible new treatment methods for a rare, usually fatal brain disease.

GSK Receives Positive CHMP Opinion in Europe for Asthma Therapeutic
Monday, September 28, 2015
GlaxoSmithKline has announced that the CHMP of the EMA has issued a positive opinion recommending marketing authorisation for mepolizumab, which will be commercialised under the brand name Nucala, as an add-on treatment for severe refractory eosinophilic asthma in adult patients.

Intarcia Announces Acquisition of Phoundry Pharmaceuticals
Monday, September 28, 2015
Founded in 2015 after six years of work as part of the Enteroendocrine Discovery Performance Unit of GlaxoSmithKline, Phoundry Pharmaceuticals has created a portfolio of optimized peptides in various therapeutic categories, most notably diabetes and obesity.

Aduro Biotech to Purchase BioNovion
Monday, September 28, 2015
The acquisition will further strengthen and expand Aduro's immunotherapy capabilities to now encompass monoclonal antibodies, including preclinical assets that inhibit clinically validated immune checkpoint pathways.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1676

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos